GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study Meeting Abstract

International Collaboration

cited authors

  • Thennati, Rajamannar; Burade, Vinod; Natarajan, Muthukumaran; Shahi, Pradeep; Nagaraja, Ravishankara; Agrawal, Sudeep; Jandrain, Bernard; Duvauchelle, Thierry; Pratley, Richard E.; Thorens, Bernard; Vilsboll, Tina; Loomba, Rohit

Publication Date

  • June 1, 2024

webpage

published in

category

start page

  • S615

end page

  • S616

volume

  • 80